Terms: = Skin cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1
43 results:
1. Lactiplantibacillus plantarum K8 lysates regulate hypoxia-induced gene expression.
Jeong J; Kang BH; Ju S; Park NY; Kim D; Dinh NTB; Lee J; Rhee CY; Cho DH; Kim H; Chung DK; Bunch H
Sci Rep; 2024 Mar; 14(1):6275. PubMed ID: 38491188
[TBL] [Abstract] [Full Text] [Related]
2. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
3. Brain and/or Spinal Cord Tumors Accompanied with Other Diseases or Syndromes.
Capitanio JF; Mortini P
Adv Exp Med Biol; 2023; 1405():645-672. PubMed ID: 37452957
[TBL] [Abstract] [Full Text] [Related]
4. The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma.
Schieven SM; Traets JJH; Vliet AV; Baalen MV; Song JY; Guimaraes MDS; Kuilman T; Peeper DS
Mol Cancer Res; 2023 May; 21(5):428-443. PubMed ID: 36753617
[TBL] [Abstract] [Full Text] [Related]
5. The road to systemic therapy in von Hippel-Lindau (vhl) disease: Are we there yet?
Shepherd STC; Drake WM; Turajlic S
Eur J Cancer; 2023 Mar; 182():15-22. PubMed ID: 36708612
[TBL] [Abstract] [Full Text] [Related]
6. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
[TBL] [Abstract] [Full Text] [Related]
7. Case report: a synonymous vhl mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
[TBL] [Abstract] [Full Text] [Related]
8. Biomarkers of Targeted Therapy and Immuno-Oncology in cancers Metastatic to the Breast.
Vranic S; Senarathne W; Stafford P; Poorman K; Pockaj BA; Gatalica Z
Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):661-668. PubMed ID: 31517642
[TBL] [Abstract] [Full Text] [Related]
9. Familial Kidney cancer: Implications of New Syndromes and Molecular Insights.
Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
[TBL] [Abstract] [Full Text] [Related]
10. Review: Warburg effect and renal cancer caused by errs in fumarate hydratase encoding gene.
Qureshi AS; Ali S
Pak J Pharm Sci; 2019 Mar; 32(2):743-749. PubMed ID: 31081789
[TBL] [Abstract] [Full Text] [Related]
11. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract] [Full Text] [Related]
12. Nutritional status at diagnosis of cancer in children and adolescents in Guatemala and its relationship to socioeconomic disadvantage: A retrospective cohort study.
Villanueva G; Blanco J; Rivas S; Molina AL; Lopez N; Fuentes AL; Muller L; Caceres A; Antillon F; Ladas E; Barr RD
Pediatr Blood Cancer; 2019 Jun; 66(6):e27647. PubMed ID: 30729661
[TBL] [Abstract] [Full Text] [Related]
13. The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.
Hamaidi I; Coquard C; Danilin S; Dormoy V; Béraud C; Rothhut S; Barthelmebs M; Benkirane-Jessel N; Lindner V; Lang H; Massfelder T
Oncogene; 2019 Jan; 38(1):60-72. PubMed ID: 30076415
[TBL] [Abstract] [Full Text] [Related]
14. Hemangioblastoma in Hereditary Leiomyomatosis and Renal Cell cancer Syndrome: a phenotypic overlap between vhl and HLRCC Syndromes.
Dow E; Winship IM
Fam Cancer; 2019 Jan; 18(1):91-95. PubMed ID: 29619618
[TBL] [Abstract] [Full Text] [Related]
15. A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines.
Aurich MK; Fleming RMT; Thiele I
PLoS Comput Biol; 2017 Aug; 13(8):e1005698. PubMed ID: 28806730
[TBL] [Abstract] [Full Text] [Related]
16. Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer.
Bartram MP; Mishra T; Reintjes N; Fabretti F; Gharbi H; Adam AC; Göbel H; Franke M; Schermer B; Haneder S; Benzing T; Beck BB; Müller RU
BMC Med Genet; 2017 May; 18(1):53. PubMed ID: 28499369
[TBL] [Abstract] [Full Text] [Related]
17. Influence of allelic Variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab.
Muñoz C; Caballero M; Hakim S; Verger E; Grau JJ
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2193-9. PubMed ID: 26245169
[TBL] [Abstract] [Full Text] [Related]
18. HIF targets in bone remodeling and metastatic disease.
Johnson RW; Schipani E; Giaccia AJ
Pharmacol Ther; 2015 Jun; 150():169-77. PubMed ID: 25681658
[TBL] [Abstract] [Full Text] [Related]
19. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
[TBL] [Abstract] [Full Text] [Related]
20. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen.
Doedens AL; Phan AT; Stradner MH; Fujimoto JK; Nguyen JV; Yang E; Johnson RS; Goldrath AW
Nat Immunol; 2013 Nov; 14(11):1173-82. PubMed ID: 24076634
[TBL] [Abstract] [Full Text] [Related]
[Next]
